Beste apotheek van Nederland

John H, Lehmann K, Hauri D. Intraurethral prostaglandin
improves quality of vacuum erection therapy. Eur Urol
1996;29(2):224-226.
Juergense P H, Botev R, Wuerth D et al. Erectile dysfunction in
chronic peritoneal dialysis patients: incidence and treatment
with sildenafil. Perit Dial Int 2001;21(4):355-359.
Kadioglu A, Erdogru T, Tellaloglu S. Combined intracavernous
injection of papaverine and stimulation (CIS) test. J Androl
1994;15 Suppl50S-53S.
Kaplan B, Ben-Rafael Z, Peled Y et al. Oral sildenafil may
reverse secondary ejaculatory dysfunction during infertility
treatment. Fertility & Sterility 1999;72(6):1144-1145.
Kaplan Helen S. The combined use of sex therapy and
intrapenile injections in the treatment of impotence. J Sex
Marital Ther 1990;16(4):195-207.
Kaplan S A, Reis R B, Kohn I J et al. Combination therapy
using oral alpha-blockers and intracavernosal injection in men
with erectile dysfunction. Urology 1998;52(5):739-743.
Karabulut A, Peskircioglu L, Ozkardes H et al. Objective penile
vascular response to intraurethral prostaglandin E2
(dinoprostone). Urol Int 2001;67(2):160-162.
Kassouf W, Carrier S. A comparison of the International Index
of Erectile Function and erectile dysfunction studies.. BJU Int
2003;91(7):667-669.
Katlowitz N M, Albano G J, Morales P et al. Potentiation of
drug-induced erection with audiovisual sexual stimulation.
Urology 1993;41(5):431-434.
Katlowitz N, Albano G J, Patsias G et al. Effect of multidose
intracorporeal injection and audiovisual sexual stimulation in
vasculogenic impotence. Urology 1993;42(6):695-697.
Kattan S A. The acceptance of satisfaction of Saudi males to
vasoactive autoinjection intracavernous therapy, external
negative pressure device and penile prosthesis in the treatment
of erectile dysfunction. Ann Saudi Med 2002;22(3-4):149-152.
Kaufman J M, Hatzichristou D G, Mulhall J P et al. Impotence
and chronic renal failure: a study of the hemodynamic
pathophysiology. Br J Urol 1994;151(3):612-618.
Keating G M, Scott L J. Vardenafil: a review of its use in
erectile dysfunction. Drugs 2003;63(23):2673-2703.
Keating G M, Scott L J. Spotlight on vardenafil in erectile
dysfunction. Drugs Aging 2004;21(2):135-140.
Kedia S, Zippe C D, Agarwal A et al. Treatment of erectile
dysfunction with sildenafil citrate (Viagra) after radiation
therapy for prostate cancer. Urology 1999;54(2):308-312.
Kendirci M, Bivalacqua T J, Hellstrom W J. Vardenafil: a novel
type 5 phosphodiesterase inhibitor for the treatment of erectile
dysfunction. Expert Opin Pharmacother 2004;5(4):923-932.
Khan M A, Raistrick M, Mikhailidis D P et al. MUSE:
clinical experience. Current Medical Research &
Opinion 2002;18(2):64-67.
Khan M M, Khwaja M. Open label study of
intracavernous injection of alpostadil alphadex in the
treatment of erectile dysfunction. J Postgrad Med Inst
2005;19(1):52-57.
Kim E D, McVary K T. Topical prostaglandin-E1 for
the treatment of erectile dysfunction.. Br J Urol
1995;153(6):1828-1830.
Kim E D, el-Rashidy R, McVary K T. Papaverine
topical gel for treatment of erectile dysfunction. Br J
Urol 1995;153(2):361-365.
Kim J M, Joh Y D, Huh J D et al. Doppler sonography
of the penile cavernosal artery: comparison of
intraurethral instillation and intracorporeal injection of
prostaglandin E1. J Clin Ultrasound 2001;29(5):273­
278.
Kim N N, Christianson D W, Traish A M. Role of
arginase in the male and female sexual arousal
response. Br J Nutr 2004;134(10 SUPPL.):2873S­
2879S.
Kim S C, Ahn T Y, Choi H K et al. Multicenter study
of the treatment of erectile dysfunction with
transurethral alprostadil (MUSE) in Korea. Int J Impot
Res 2000;12(2):97-101.
Kim S C, Chang I H, Jeon H J. Preference for oral
sildenafil or intracavernosal injection in patients with
erectile dysfunction already using intracavernosal
injection for > 1 year. BJU Int 2003;92(3):277-280.
Kim S C, Lee S W, Seo K K. Characteristics of pain
following intracavernous injection of prostaglandin
E1. J Korean Med Sci 1997;12(4):327-331.
Kloner R A. Cardiovascular risk and sildenafil.
[Review] [27 refs]. Am J Cardiol 2000;86(2A):57F­
61F.
Kloner R A, Zusman R M. Cardiovascular effects of
sildenafil citrate and recommendations for its use.
[Review] [21 refs]. Am J Cardiol 1999;84(5B):11N­
17N.
Kloner R A, Brown M, Prisant L M et al. Effect of
sildenafil in patients with erectile dysfunction taking
antihypertensive therapy. Sildenafil Study Group. Am
J Hypertens 2001;14(1):70-73.
Kloner R A, Mitchell M, Emmick J T. Cardiovascular
effects of tadalafil in patients on common
antihypertensive therapies. [Review] [5 refs]. Am J
Cardiol 2003;92(9A):47M-57M.
D-171